Shares of Horizon Pharma PLC (NASDAQ:HZNP) plunged nearly 20% today following a lawsuit filed by Express Scripts and recent allegations. Express Scripts cut the pharmacy Linden …
Mizuho Securities analyst Irina Rivkind Koffler rates stocks in the biotechnology sector and is one of the top 10 analysts rated on TipRanks. Today, …
Mizuho Securities’ healthcare analyst Irina Rivkind Koffler weighed in today with her views on Valeant Pharmaceuticals Intl Inc (NYSE:VRX), after Citron Research said in a report that it …
On June 17, Synergy Pharmaceuticals Inc (NASDAQ:SGYP) announced positive results from the first Phase 3 Trial of plecanatide in patients with chronic idiopathic …
Oracle Corporation (NYSE:ORCL) fell -6.3% in pre-market trading to $42.
Synergy Pharmaceuticals (NASDAQ:SGYP) price target has been increased at Cantor analyst by research analyst Irina Rivkind Koffler from $8.00 to $14.
In a research report issued today, Cantor analyst Irina Rivkind Koffler maintained a Buy rating on Synergy Pharmaceuticals Inc (NASDAQ:SGYP) with an $8.50 price target, after …
The first quarter of 2015 has come to a close and companies are still releasing earnings reports. Let’s look back and see which …
Cantor’s healthcare analyst Irina Rivkind Koffler weighed in with a cautious stance on shares of Pernix Therapeutics Holdings Inc (NASDAQ:PTX), reducing the price target to $8.50 (from $11.
By Sarah Roden Valeant Pharmaceuticals (NYSE:VRX) beat out Endo International in a battle to take over Salix Pharmaceuticals (NASDAQ:SLXP) in a deal valued …
